AU1088595A - Lymphotropic agents and vectors - Google Patents

Lymphotropic agents and vectors

Info

Publication number
AU1088595A
AU1088595A AU10885/95A AU1088595A AU1088595A AU 1088595 A AU1088595 A AU 1088595A AU 10885/95 A AU10885/95 A AU 10885/95A AU 1088595 A AU1088595 A AU 1088595A AU 1088595 A AU1088595 A AU 1088595A
Authority
AU
Australia
Prior art keywords
lymphotropic
vectors
agents
lymphotropic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10885/95A
Inventor
Nitza Frenkel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Original Assignee
Ramot Univ Authority For Applied Research And Industrial Development Ltd
Ramot at Tel Aviv University Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot Univ Authority For Applied Research And Industrial Development Ltd, Ramot at Tel Aviv University Ltd filed Critical Ramot Univ Authority For Applied Research And Industrial Development Ltd
Publication of AU1088595A publication Critical patent/AU1088595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16541—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16543—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16541—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16545—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU10885/95A 1993-11-10 1994-11-09 Lymphotropic agents and vectors Abandoned AU1088595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL107557 1993-11-10
IL10755793A IL107557A (en) 1993-11-10 1993-11-10 Lymphotropic agents and vectors
PCT/US1994/012715 WO1995013081A1 (en) 1993-11-10 1994-11-09 Lymphotropic agents and vectors

Publications (1)

Publication Number Publication Date
AU1088595A true AU1088595A (en) 1995-05-29

Family

ID=11065437

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10885/95A Abandoned AU1088595A (en) 1993-11-10 1994-11-09 Lymphotropic agents and vectors

Country Status (3)

Country Link
AU (1) AU1088595A (en)
IL (1) IL107557A (en)
WO (1) WO1995013081A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2008047656A1 (en) 2006-10-12 2010-02-25 株式会社カネカ Method for producing L-amino acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242820A (en) * 1986-06-18 1993-09-07 American Registry Of Pathology Pathogenic mycoplasma
US5230997A (en) * 1990-07-19 1993-07-27 The United States Of America As Represented By The Department Of Health And Human Services Methods of detecting the presence of human herpesvirus-7 infection
DE4110962A1 (en) * 1991-04-05 1992-10-08 Bayer Ag EQUINE HERPESVIREN (EHV) CONTAINING FOREIGN DNA, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN Vaccines

Also Published As

Publication number Publication date
WO1995013081A1 (en) 1995-05-18
IL107557A0 (en) 1994-02-27
IL107557A (en) 2005-06-19

Similar Documents

Publication Publication Date Title
AU645342B2 (en) Antimicrobial peptides and an antimicrobial agent
AU6072994A (en) Tri-carbamate-functional crosslinking agents
AU6909194A (en) Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole
AU5619894A (en) Dna-armed ribozymes and minizymes
AU6592594A (en) Hysterosalpingography and selective salpingography
AU663637B2 (en) Solutions and their preparation
AU7652994A (en) Sunscreen agents
AU7767794A (en) Packages and their manufacture
AU7446194A (en) 4-arylamino-benzopyran and related compounds
AU5131493A (en) Improved semiconductor architecture and application therefor
AU6120994A (en) Anticonvulsive agents and uses thereof
GB2281830B (en) I/q-modulator and i/q-demodulator
AU7404594A (en) Selective amylin antagonist peptides and uses therefor
AU7716694A (en) Anti-dyslipidemic agents
AU7019794A (en) Oligomer conjugates and their use
GB9322576D0 (en) Antihaemostatic agents
AU6544294A (en) Polystyrene-dissolving agent
AU6809594A (en) Colletotrichum and use thereof
ZA941612B (en) p-Dinitrosobenzene
AU7677194A (en) Sulfamethoxazole-specific immunosuppressive agents
AU7075694A (en) Novel cross-linking agents and use thereof
AU1088595A (en) Lymphotropic agents and vectors
AU1292995A (en) Bis-oxazolidine compounds and their use
GB9303850D0 (en) Vector
AU7078094A (en) Allatostatins and their use